DBV TECHNOLOGIES SA (DBVT) Announces Regulatory Update
DBV TECHNOLOGIES SA (DBVT) provided an update on regulatory developments for its product portfolio.
Regulatory Update Details:
• Applications: BLA (Biologics License Application), NDA (New Drug Application)
• Regulatory Agencies: FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency)
• Status: Approved, Rejected
Clinical Development:
📋 DBV TECHNOLOGIES SA (DBVT) - Regulatory Update
Filing Date: 2026-06-29
Accepted: 2026-06-29 16:28:49
Event Type: Regulatory Update
Event Details:
💼 Business Developments:
Structured Data: